Figure 2.
COVID-19 nine-point ordinal scale score by day. A, Ruxolitinib 15 mg twice a day (BID), B, ruxolitinib 5 mg BID, or C, placebo (intention-to-treat population). LTFU = lost to follow-up.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.